rs35233100

This variant is located in the MADD gene.

GWAS Catalog Trait Associations (4)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

glucose measurement

Sinnott-Armstrong N et al. Genetics of 35 blood and urine biomarkers in the UK Biobank. Nature Genetics 53(2):185-194 (2021)
Allele T
OR 0.04
p 1.0e-15
N 325,386
Major Consortium StudyLarge GWAS
multi-ancestry

insulin measurement

Allele T
OR 0.10
p 8.0e-15
N 8,229
Large GWAS
European

HbA1c measurement

Sinnott-Armstrong N et al. Genetics of 35 blood and urine biomarkers in the UK Biobank. Nature Genetics 53(2):185-194 (2021)
Allele T
OR 0.04
p 1.0e-14
N 338,919
Major Consortium StudyLarge GWAS
multi-ancestry
Allele T
OR 0.01
p 1.0e-8
N 144,060
Large GWAS
multi-ancestry

chronotype measurement

Allele T
OR 0.02
p 4.0e-12
N 449,734
Large GWAS
European

ClinVar annotation

Benign
2 submitters

MADD-related disorder; Hepatocellular carcinoma; Adrenocortical carcinoma, hereditary; Uveal melanoma; Malignant lymphoma, large B-cell, diffuse; Colon adenocarcinoma; Colorectal cancer; Uterine corpus endometrial carcinoma; Lymphoma; Cholangiocarcinoma; Thymoma; Acute myeloid leukemia

View on ClinVar →

About MADD

Tumor necrosis factor alpha (TNF-alpha) is a signaling molecule that interacts with one of two receptors on cells targeted for apoptosis. The apoptotic signal is transduced inside these cells by cytoplasmic adaptor proteins. The protein encoded by this gene is a death domain-containing adaptor protein that interacts with the death domain of TNF-alpha receptor 1 to activate mitogen-activated protein kinase (MAPK) and propagate the apoptotic signal. It is membrane-bound and expressed at a higher level in neoplastic cells than in normal cells. Several transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]

View all MADD variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…